MHC antigen expression in human oral squamous carcinoma cell lines

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Major Histocompatibility Complex (MHC) antigens are crucial for immune surveillance.
• Aberrant MHC expression is a hallmark of various cancers, including oral malignancies.
• Interferon-gamma (IFN-gamma) is a key cytokine modulating immune responses and MHC expression.

Purpose of the Study:

• To quantify constitutive and IFN-gamma-stimulated MHC class I and II antigen expression on normal and malignant oral keratinocytes.
• To identify aberrant MHC expression patterns in oral cancer cell lines.
• To investigate the differential response of oral keratinocytes to IFN-gamma stimulation.

Main Methods:

• Radioimmunoassay and immunocytochemical techniques were employed.
• Expression levels of MHC class I (HLA-ABC, beta 2 microglobulin) and class II (HLA-DR, -DP, -DQ) antigens were assessed.
• Normal oral keratinocytes and four oral malignant cell lines were analyzed.

Main Results:

• Normal and most malignant oral keratinocytes constitutively expressed MHC class I; IFN-gamma upregulated MHC class I in normals and some malignant lines.
• MHC class II antigens were largely absent constitutively but induced by IFN-gamma in normals and some malignant lines.
• One malignant cell line (H191) showed a complete lack of MHC expression, while others displayed varied, aberrant patterns.

Conclusions:

• Malignant oral keratinocytes exhibit diverse and aberrant patterns of MHC class I and II antigen expression compared to normal cells.
• IFN-gamma differentially affects MHC expression in normal and malignant oral keratinocytes.
• These findings highlight the complex role of MHC molecules in oral carcinogenesis and immune evasion.